Osteoporosis, Postmenopausal

Explore clinical trials studying Osteoporosis, Postmenopausal. Study availability and eligibility vary by location and protocol.

277 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Osteoporosis, Postmenopausal trial results

Active, Not Recruiting

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

NCT04467983

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations: Hospital for Special Surgery New York, United States

View Trial Details

Active, Not Recruiting

Anabolic Therapy in Postmenopausal Osteoporosis

NCT05010590

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Romosozumab Use to Build Skeletal Integrity

NCT05058976

Conditions: Bone Diseases, Bone Diseases, Metabolic, Fractures, Bone, +8 more
Locations: UPMC Senior Communities Pittsburgh, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)

NCT06577935

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Center for Advanced Research & Education Gainesville, Georgia, United States

NM Clinical Research & Osteoporosis Center, Inc. Albuquerque, New Mexico, United States

Altoona Center for Clinical Research Duncansville, Pennsylvania, United States

View all 23 locations

View Trial Details

Active, Not Recruiting

Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)

NCT05655013

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations: Aarhus University Hospital Aarhus, Denmark

View Trial Details

Active, Not Recruiting

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

NCT03623633

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP

NCT03692143

Conditions: Back Injuries, Bone Diseases, Bone Diseases, Metabolic, +11 more
Locations: Not specified

View Trial Details

Osteoporosis, Postmenopausal

Osteoporosis, Postmenopausal trial results

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

Anabolic Therapy in Postmenopausal Osteoporosis

Romosozumab Use to Build Skeletal Integrity

A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)

Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP

Related conditions